Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study.

Breast · 2023 · PMC10272493 · PMID 37295176

Europe PMC DOI

hedged sentence

0.1670

closest p · 3.3× alpha

0.1670

boldest claim

The sentences

did not reach statistical significanceP = 0.167not close (p > 0.1)

There was a trend of higher adjusted 10-year OS in the Stockholm cohort compared to the Skane cohort but this trend did not reach statistical significance (82.5% vs 78.3%, HR 1.22, P = 0.167) ( Fig. 2 D).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.